CTOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Carla Vista Sober Living

Piety Corner Nursing Home

Piety Corner Nursing Home is a Waltham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Amerihealth Mercy Health Plan

Amerihealth Mercy Health Plan is a Harrisburg, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Professionals

Medical Professionals is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Intrinsic Therapeutics

Intrinsic Therapeutics, Inc is a MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.